Vatelizumab

( DrugBank: Vatelizumab / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	6

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	10

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

trials per page:

Showing 1 to 6 of 6 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-001643-20-SE (EUCTR)	03/07/2015	19/01/2015	Efficacy and Safety of Vatelizumab in Patients with Relapsing Remitting Multiple Sclerosis	A Phase 2a/2b Double-Blind, Randomized, Placebo-Controlled Study Assessing Efficacy, Safety, and Dos ...	Nervous System Diseases MedDRA version: 17.1;Level: PT;Classification code 10063399;Term: Relapsing- ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab Other descriptive name: CHR-1103 / GBR500	Genzyme Corporation	NULL	Not Recruiting			Female: yes Male: yes	168	Phase 2	Germany;Italy;Switzerland;Sweden;United States;Czech Republic;Mexico;Canada;Poland;Russian Federatio ...
2	EUCTR2014-003265-19-PL (EUCTR)	12/05/2015	26/02/2015	Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839	A Long-Term Follow-up Study Assessing the Safety and Efficacy of Vatelizumabin Multiple Sclerosis (M ...	Relapsing-remitting multiple sclerosis MedDRA version: 18.0;Level: PT;Classification code 10063399;T ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab Other descriptive name: CHR-1103 / GBR500	Genzyme Corporation	NULL	Not Recruiting			Female: yes Male: yes	168	Phase 2	United States;Czech Republic;Mexico;Canada;Poland;Russian Federation;Germany;Italy;Switzerland;Swede ...
3	EUCTR2014-001643-20-DE (EUCTR)	10/02/2015	18/08/2014	Efficacy and Safety of Vatelizumab in Patients with Relapsing Remitting Multiple Sclerosis	A Phase 2a/2b Double-Blind, Randomized, Placebo-Controlled Study Assessing Efficacy, Safety, and Dos ...	Nervous System Diseases MedDRA version: 18.0;Level: PT;Classification code 10063399;Term: Relapsing- ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab Other descriptive name: CHR-1103 / GBR500 Prod ...	Genzyme Corporation	NULL	Not Recruiting			Female: yes Male: yes	168	Phase 2	United States;Czech Republic;Mexico;Canada;Poland;Russian Federation;Germany;Italy;Switzerland;Swede ...
4	NCT02306811 (ClinicalTrials.gov)	February 2015	1/12/2014	Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839	A Long-Term Follow-up Study Assessing the Safety and Efficacy of Vatelizumabin Multiple Sclerosis (M ...	Relapsing-remitting Multiple Sclerosis	Drug: Vatelizumab	Genzyme, a Sanofi Company	NULL	Terminated	18 Years	N/A	Both	62	Phase 2	United States;Canada;Poland;Russian Federation
5	EUCTR2014-001643-20-PL (EUCTR)	23/01/2015	31/10/2014	Efficacy and Safety of Vatelizumab in Patients with Relapsing Remitting Multiple Sclerosis	A Phase 2a/2b Double-Blind, Randomized, Placebo-Controlled Study Assessing Efficacy, Safety, and Dos ...	Nervous System Diseases MedDRA version: 18.1;Level: PT;Classification code 10063399;Term: Relapsing- ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab Other descriptive name: CHR-1103 / GBR500	Genzyme Corporation	NULL	Not Recruiting			Female: yes Male: yes	168	Phase 2	United States;Czech Republic;Mexico;Canada;Poland;Russian Federation;Germany;Italy;Switzerland;Swede ...
6	NCT02222948 (ClinicalTrials.gov)	September 2014	20/8/2014	Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis	A Phase 2a/2b Double-Blind, Randomized, Placebo-Controlled Study Assessing Efficacy, Safety, and Dos ...	Relapsing-remitting Multiple Sclerosis	Drug: Vatelizumab;Drug: Placebo (for Vatelizumab)	Genzyme, a Sanofi Company	NULL	Terminated	18 Years	55 Years	Both	112	Phase 2	United States;Canada;Poland;Russian Federation;Sweden

First Previous1Next Last

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 10 of 10 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2013-001012-30-DE (EUCTR)	20/01/2014	07/10/2013	Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)	A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability ...	Ulcerative Colitis MedDRA version: 16.0;Level: PT;Classification code 10009900;Term: Colitis ulcerat ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab Other descriptive name: SAR339658	Sanofi-aventis recherche & développement	NULL	Not Recruiting	Female: yes Male: yes	80		United States;Canada;Poland;Belgium;Austria;Germany;Italy
2	EUCTR2013-001012-30-PL (EUCTR)	17/10/2013	05/09/2013	Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)	A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability ...	Ulcerative Colitis MedDRA version: 16.1;Level: PT;Classification code 10009900;Term: Colitis ulcerat ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab Other descriptive name: SAR339658	Sanofi-aventis recherche & développement	NULL	Not Recruiting	Female: yes Male: yes	80		United States;Canada;Poland;Austria;Germany;Italy
3	EUCTR2013-001012-30-BE (EUCTR)	09/10/2013	12/08/2013	Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)	A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability ...	Ulcerative Colitis MedDRA version: 16.0;Level: PT;Classification code 10009900;Term: Colitis ulcerat ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab Other descriptive name: SAR339658	Sanofi-aventis recherche & développement	NULL	Not Recruiting	Female: yes Male: yes	80	Phase 2	United States;Canada;Poland;Belgium;Austria;Germany;Italy
4	EUCTR2013-001012-30-IT (EUCTR)	30/09/2013	02/07/2013	Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)	A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability ...	Ulcerative Colitis MedDRA version: 16.0;Level: PT;Classification code 10009900;Term: Colitis ulcerat ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab Other descriptive name: SAR339658	Sanofi-aventis recherche & développement	NULL	Not Recruiting	Female: yes Male: yes	80		United States;Canada;Poland;Austria;Germany;Italy
5	EUCTR2012-002013-19-DE (EUCTR)	25/09/2013	17/05/2013	Efficacy and Safety of SAR339658 in Patients with Moderate to Severe Ulcerative Colitis	A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of ...	Ulcerative Colitis MedDRA version: 14.1;Level: PT;Classification code 10009900;Term: Colitis ulcerat ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab	Sanofi aventis Recherche&Développement	NULL	Not Recruiting	Female: yes Male: yes	93		France;United States;Canada;Belgium;Poland;Austria;Germany;Italy
6	EUCTR2012-002013-19-PL (EUCTR)	12/09/2013	14/06/2013	Efficacy and Safety of SAR339658 in Patients with Moderate to Severe Ulcerative Colitis	A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of ...	Ulcerative Colitis MedDRA version: 16.0;Level: PT;Classification code 10009900;Term: Colitis ulcerat ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab	Sanofi aventis Recherche&Développement	NULL	Not Recruiting	Female: yes Male: yes	93		France;United States;Canada;Belgium;Poland;Austria;Germany;Italy
7	EUCTR2013-001012-30-AT (EUCTR)	04/09/2013	12/07/2013	Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)	A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability ...	Ulcerative Colitis MedDRA version: 16.0;Level: PT;Classification code 10009900;Term: Colitis ulcerat ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab Other descriptive name: SAR339658	Sanofi-aventis recherche & développement	NULL	Not Recruiting	Female: yes Male: yes	80		United States;Canada;Poland;Austria;Germany;Italy
8	EUCTR2012-002013-19-BE (EUCTR)	19/07/2013	19/02/2013	Efficacy and Safety of SAR339658 in Patients with Moderate to Severe Ulcerative Colitis	A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of ...	Ulcerative Colitis MedDRA version: 14.1;Level: PT;Classification code 10009900;Term: Colitis ulcerat ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab	Sanofi aventis Recherche&Développement	NULL	Not Recruiting	Female: yes Male: yes	93	Phase 2	France;United States;Canada;Poland;Belgium;Austria;Germany;Italy
9	EUCTR2012-002013-19-IT (EUCTR)	02/06/2013	08/04/2013	Efficacy and Safety of SAR339658 in Patients with Moderate to Severe Ulcerative Colitis	A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of ...	Ulcerative Colitis MedDRA version: 14.1;Level: PT;Classification code 10009900;Term: Colitis ulcerat ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab	Sanofi aventis Recherche&Développement	NULL	Not Recruiting	Female: yes Male: yes	93		United States;France;Canada;Poland;Belgium;Austria;Germany;Italy
10	EUCTR2012-002013-19-AT (EUCTR)	16/04/2013	21/03/2013	Efficacy and Safety of SAR339658 in Patients with Moderate to Severe Ulcerative Colitis	A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of ...	Ulcerative Colitis MedDRA version: 16.0;Level: PT;Classification code 10009900;Term: Colitis ulcerat ...	Product Code: SAR339658 INN or Proposed INN: Vatelizumab	Sanofi aventis Recherche&Développement	NULL	Not Recruiting	Female: yes Male: yes	93		France;United States;Canada;Belgium;Poland;Austria;Germany;Italy

First Previous1Next Last